See also this year's filing and all EDGAR filings for this company.
PDF Report 0001261249_2023_AGILE_THERAPEUTICS_INC.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001261249, AGILE THERAPEUTICS INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 11,358,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 177,000 |
| 3 | remainder_Assets | 2,707,000 |
| 4 | LiabilitiesCurrent | 13,387,000 |
| 5 | LiabilitiesNoncurrent | 466,000 |
| 6 | remainder_Liabilities | 5,934,000 |
| 7 | CostOfGoodsAndServicesSold | 6,836,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,860,000 |
| 9 | ResearchAndDevelopmentExpense | 3,253,000 |
| 10 | remainder_Expenses | 36,816,000 |
| 11 | remainder_Revenues | 10,884,000 |
| 12 | remainder_NetIncome | 22,469,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 14,242,000 |
| 1 | Liabilities | 19,787,000 |
| 2 | Expenses | 58,765,000 |
| 3 | Revenues | 10,884,000 |
| 4 | StockholdersEquity | -5,545,000 |
| 5 | NetIncome | -25,412,000 |
| 6 | ComprehensiveNetIncome | -25,412,000 |
| 7 | BaseVar | 63,073,500 |
| 8 | EconomicCapitalRatio | -2.05 |